Praxis Home (PRAXIS)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹6.21 |
| Market Cap | ₹115.39 Cr |
| P/E Ratio | 0 |
| ROCE | -9.63% |
| ROE | -67.89% |
| Dividend Yield | 0% |
| Profit Growth | -90.76% |
| Debt/Equity | 3.1 |
| Sales Growth | 13.2% |
| Promoter Holding | 7.23% |
| 52-Week Range | ₹4.29 — ₹14.44 |
| Sector | Retailing |
| Book Value | ₹-4.16 |
Strengths
- Book value per share is ₹3.34, so assets still exceed liabilities despite recent losses.
- Quarterly sales of ₹26 Cr annualise to roughly ₹104 Cr against a ₹145 Cr market cap, so the revenue multiple is not extreme.
- A small market cap of ₹145 Cr means a successful restructure could produce sharp earnings leverage if operations improve.
Concerns
- Latest quarter net loss of ₹16 Cr on sales of ₹26 Cr reflects a deeply negative and unsustainable margin.
- Debt/equity of 3.10 with negative ROE and ROCE shows high leverage amplifying losses.
- Promoter holding of only 7.23% raises serious governance and alignment concerns.
- Piotroski F-score of 2/9 and sales decline of 22.85% point to continuing fundamental deterioration.
AI Analysis
Let me be blunt: this is not a business I would buy at any price. Praxis Home lacks the first requirement of any investment—a profitable, durable operation. Latest quarter revenue was ₹26 Cr and net loss was ₹16 Cr, so the company is losing far more than half of every sales rupee. Sales have shrunk by 22.85%, and the bottom line has deteriorated sharply. Return on equity is -67.89% and ROCE is -9.63%; this is a business destroying shareholder value and not earning its cost of capital. The balance sheet deepens my concern: debt/equity is 3.10, so the company is highly leveraged while trying to fund losses. Book value is ₹3.34 per share, and the shares trade at ₹7.31, 2.19 times book—for a losing, leveraged retailer. Graham would demand a margin of safety; here the price provides none. The Piotroski F-score of 2/9 is a distressing signal, and the promoter holding of only 7.23% shows that those in control have very little skin in the game. As a speciality retailer, Praxis Home looks moatless: falling sales and deep losses suggest no pricing power and intense competition. This is not a stalwart or a fast grower; the only category that could apply is a turnaround, but a turnaround needs visible catalysts—stabilising revenues, a credible cost structure, debt reduction, and owners willing to put in more capital. I see none of these today. A low price of ₹7.31, near the ₹5.26 low and far below the ₹14.44 high, is not enough. Without evidence of sustainable earnings or a clear path to profitability, I treat Praxis Home as a value trap and pass.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer